These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3552512)

  • 1. Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve.
    Clarson C; Daneman D; Drash AL; Becker DJ; Ehrlich RM
    Diabetes Care; 1987; 10(1):33-8. PubMed ID: 3552512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual beta-cell function in children with type 1 diabetes: measurement and impact on glycemic control.
    Daneman D; Clarson C
    Clin Invest Med; 1987 Sep; 10(5):484-7. PubMed ID: 3315370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.
    Sochett EB; Daneman D; Clarson C; Ehrlich RM
    Diabetologia; 1987 Jul; 30(7):453-9. PubMed ID: 3311859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study).
    Pozzilli P; Visalli N; Cavallo MG; Signore A; Baroni MG; Buzzetti R; Fioriti E; Mesturino C; Fiori R; Romiti A; Giovannini C; Lucentini L; Matteoli MC; Crinò A; Teodonio C; Paci F; Amoretti R; Pisano L; Suraci C; Multari G; Suppa M; Sulli N; De Mattia G; Faldetta MR
    Eur J Endocrinol; 1997 Sep; 137(3):234-9. PubMed ID: 9330586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
    Schnell O; Eisfelder B; Standl E; Ziegler AG
    Diabetes; 1997 Oct; 46(10):1607-11. PubMed ID: 9313757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
    Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children].
    Szadkowska A; Pietrzak I; Markuszewski L; Bodalski J
    Med Wieku Rozwoj; 2005; 9(2):223-34. PubMed ID: 16085963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting course of beta-cell function in IDDM.
    Schiffrin A; Suissa S; Weitzner G; Poussier P; Lalla D
    Diabetes Care; 1992 Aug; 15(8):997-1001. PubMed ID: 1505333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission phase, endogenous insulin secretion and metabolic control in diabetic children.
    Knip M; Puukka R; Käär ML; Akerblom HK
    Acta Diabetol Lat; 1982; 19(3):243-51. PubMed ID: 6756005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
    Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ
    Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell function and diabetic control in insulin dependent diabetes melletus.
    Faber OK
    Acta Endocrinol Suppl (Copenh); 1985; 272():73-7. PubMed ID: 3914807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the beta cell function in type I diabetes by the determination of peptide C after glucagon challenge].
    Alpigiani MG; Gandullia E; Lattere M; De Grandi R; Bonioli E
    Pediatr Med Chir; 1990; 12(3):239-41. PubMed ID: 2274434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients.
    Agner T; Damm P; Binder C
    Diabetes Care; 1987; 10(2):164-9. PubMed ID: 3556104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
    Miki H; Matsuyama T; Fujii S; Komatsu R; Nishioeda Y; Omae T
    Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-peptide/creatinine ratio in early morning urine as an indicator of residual B-cell function in insulin-dependent diabetes.
    Sasaki N; Miyamoto S; Niimi H; Nakajima H
    Acta Paediatr Jpn; 1991 Jun; 33(3):375-80. PubMed ID: 1785335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
    Böber E; Dündar B; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):435-41. PubMed ID: 11327378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.